ASB2 p.Pro208Ser
c.622C>T · rs2295213 · VCV2252389
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7927 | likely pathogenic |
|---|---|---|
| REVEL | 0.662 | pathogenic-leaning |
| ⇒ AlphaMissense and REVEL both call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.7, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 30 kb · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 27.6 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P160S vs ClinVar P208S) — verify the residue.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ASB2
- Protein
- p.Pro208Ser
- Coding
- c.622C>T
- MANE Select
- NM_001202429
- dbSNP
- rs2295213
- Type
- single nucleotide variant
- Location
- chr14:93953364 (GRCh38)
- Gene constraint
- LOEUF 1.243 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 83.96
- Residue 208
- a UniProt-annotated variant site (in)
Similar variants
- ASB2 p.Ala132Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala196Thr Uncertain significance ★ same type
- ASB2 p.Ala212Asp Uncertain significance ★ ⚠ same type
- ASB2 p.Ala229Thr Uncertain significance ★ same type
- ASB2 p.Ala269Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala305Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala330Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala376Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/asb2-p-pro208ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown